TLDR Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.
In a retrospective case-control study with 232 patients with Lichen Planopilaris (LPP) or Frontal Fibrosing Alopecia (FFA) and 194 controls, it was found that LPP patients had significantly higher odds of having rosacea (OR 4.43) and skin cancer (OR 5.67), but no significant difference in overall cardiovascular disease compared to controls. However, LPP patients had lower odds of congestive heart failure (OR 0.28) and stroke (OR 0.23), as well as significantly lower odds of glaucoma (OR 0.034). The association between LPP and alopecia areata was not statistically significant (OR 12.94). The findings indicate a need for further research on the link between dermatologic conditions and LPP and suggest considering increased skin cancer surveillance for LPP patients. The study's retrospective design may have introduced selection bias.
21 citations,
September 2018 in “International journal of women’s dermatology” People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.
160 citations,
March 2009 in “Seminars in Cutaneous Medicine and Surgery” New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.
Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.
62 citations,
July 2018 in “Lasers in Medical Science” LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.
April 2017 in “Australasian Journal of Dermatology” The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.
13 citations,
April 2022 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia” The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.
April 2017 in “Australasian Journal of Dermatology” Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.
